Greenberg Bruce Insider Trades

Insider Trading History

Track insider trading activity for Greenberg Bruce. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $235k 126,382 shares
Last Trade
Aug 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.4k 10,834 shares
$4.74
$1.86
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $225k 120,699 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$45k 13,201 shares
$3.41
$1.86
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $242k 130,154 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$45k 13,201 shares
$3.41
$1.86
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $469k 252,280 shares
Last Trade
Mar 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$913k 252,280 shares
$3.62
$1.86
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $205k 110,028 shares
Last Trade
Feb 28, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$744k 110,028 shares
$6.76
$1.86
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $249k 133,900 shares
Last Trade
Jul 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$595k 126,087 shares
$4.72
$1.86
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
See Remarks
Holding Value $14.5k 7,813 shares
Last Trade
May 10, 2022 Sale
$857k 325,872 shares
$2.63
$1.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up